Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjeev Handa

Showing results (111-120 of 272) with videos related to

Pageof 28
Sort By:
American Journal of Clinical Dermatology|March 13, 2021
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled TrialSoufila Kt, Vishal Thakur, Tarun Narang, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 16, 2019
Successful correction of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using full thickness skin graft in resource-poor settingsSatyaswarup Tripathy, Garima Dabas, Sanjeev Handa, et al.
International Journal of Dermatology|January 21, 2021
Apremilast in treatment of palmoplantar pustulosis - a case seriesSoufila Kt, Vishal Thakur, Tarun Narang, et al.
Cutis|October 30, 2023
Effect of COVID-19 Vaccination on Disease Severity in Patients With Stable Plaque Psoriasis: A Cross-sectional StudyAdhyatm Bhandari, Tarun Narang, Kiruthika Subburaj, et al.
Pediatric Dermatology|January 22, 2005
Methotrexate for generalized pustular psoriasis in a 2-year-old childSunil Dogra, Muthu Sendhil Kumaran, Sanjeev Handa, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 15, 2023
Outcome of COVID-19 in patients with autoimmune bullous diseasesDipankar De, Raihan Ashraf, Hitaishi Mehta, et al.
Clinical and Experimental Dermatology|April 6, 2022
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigusNamrata Singh, Sanjeev Handa, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|September 19, 2025
Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohortSanjeev Handa, Anubha Dev, Anuradha Bishnoi, et al.
Indian Journal of Dermatology, Venereology and Leprology|April 10, 2024
Assessing the impact of childhood and adolescent chronic plaque psoriasis on parents/caregivers using the Family Dermatology Life Quality Index (FDLQI): A cross-sectional studyAdhyatm Bhandari, Tarun Narang, Rohit Panjiyar, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 17, 2023
Not all black fungus is mucormycosis: A challenging case of Medicopsis romeroiNeha Bhardwaj, Nithye Parvathy, Harsimran Kaur, et al.
Pageof 28

Showing results (111-120 of 272) with videos related to

Sort By:
Pageof 28
American Journal of Clinical Dermatology|March 13, 2021
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled TrialSoufila Kt, Vishal Thakur, Tarun Narang, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 16, 2019
Successful correction of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using full thickness skin graft in resource-poor settingsSatyaswarup Tripathy, Garima Dabas, Sanjeev Handa, et al.
International Journal of Dermatology|January 21, 2021
Apremilast in treatment of palmoplantar pustulosis - a case seriesSoufila Kt, Vishal Thakur, Tarun Narang, et al.
Cutis|October 30, 2023
Effect of COVID-19 Vaccination on Disease Severity in Patients With Stable Plaque Psoriasis: A Cross-sectional StudyAdhyatm Bhandari, Tarun Narang, Kiruthika Subburaj, et al.
Pediatric Dermatology|January 22, 2005
Methotrexate for generalized pustular psoriasis in a 2-year-old childSunil Dogra, Muthu Sendhil Kumaran, Sanjeev Handa, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 15, 2023
Outcome of COVID-19 in patients with autoimmune bullous diseasesDipankar De, Raihan Ashraf, Hitaishi Mehta, et al.
Clinical and Experimental Dermatology|April 6, 2022
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigusNamrata Singh, Sanjeev Handa, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|September 19, 2025
Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohortSanjeev Handa, Anubha Dev, Anuradha Bishnoi, et al.
Indian Journal of Dermatology, Venereology and Leprology|April 10, 2024
Assessing the impact of childhood and adolescent chronic plaque psoriasis on parents/caregivers using the Family Dermatology Life Quality Index (FDLQI): A cross-sectional studyAdhyatm Bhandari, Tarun Narang, Rohit Panjiyar, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 17, 2023
Not all black fungus is mucormycosis: A challenging case of Medicopsis romeroiNeha Bhardwaj, Nithye Parvathy, Harsimran Kaur, et al.
Pageof 28